For example, lincRoR has been found to act as a competing endogenous RNA of microRNA-205, which prevented the degradation of EMT inducer ZEB2 and enhanced the aggressiveness of breast cancer cells [47]. The gene discussed is ZEB2; the disease is breast carcinoma.